Podcast appearances and mentions of Peter Simons

In deze aflevering gaan we in op de vraag: "Wat is het kernprobleem in het onderwijs?". Dit onderwerp raakt zowel ouders, docenten als leerlingen. Ik ga hierover in gesprek met Peter Simons, hij deelt zijn visie op de huidige problematiek én wat er volgens hem nodig is om dit op te lossen. We gaan het hebben over de hiërarchie in het onderwijs, autonomie van de kinderen én hoe democratische scholen al werken. Hieronder de linkjes voor verdere informatie over de podcast: Maak een connectie via Linkedin met Peter Simons Boek: Je moet wel durven ervaringsverhalen over het democratisch onderwijs Overzicht van democratische scholen in NL Volg Marieke: Op Instagram of Linkedin www.mariekeringrose.nl

Peter Simons had ooit gewoon een baan en wilde zelfstandig worden. En toen sloegen allerlei angsten toe: verdien ik wel genoeg geld? kan ik de rente en aflossing betalen van de hypotheek op ons huis? ben ik wel goed verzekerd voor als mij iets overkomt? In deze podcast vertelt hij zijn verhaal. Zijn onderzoek leidt onherroepelijk naar de vraag: hoe kunnen we het huidige geldsysteem eerlijker maken? Van buitenaf of van binnenuit? En, hoe dan? Daar komen Peter en Jac samen niet helemaal uit. Desalniettemin is dit een heerlijk gesprek over geld en het jezelf bevrijden uit het geldsysteem. Meer informatie over Peter Simons en zijn vrouw Marleen, ook over hun ideeën, vind je hier: Ecologisch Samenleven.

Today we are continuing with our look behind the scenes of Mad in America for our 200th podcast. Mad in America got started in January 2012 and so to celebrate a decade of critical comment and appraisal we thought it would be interesting to reflect on Mad in America's mission and work by speaking to the people behind the scenes, who keep it running day-to-day. Before we move on to our interviews, I want to pay tribute to the people at MIA who couldn't join us for these interviews for one reason or another. Susannah Senerchia is our Assistant Editor and amongst other things, manages our Around the Web section. She is always finding interesting articles from the corners of the internet that help to tell of a shift in thinking about mental health. Also, of course, Mad in America relies heavily on the science news team as we discussed in part one of this podcast and for overview, we have our Board consisting of Robert Whitaker, Kermit Cole, Louisa Putnam, Olga Runciman and Claudia Esteve. So, on to our interviews and we hear from coordinator of our continuing education webinars, Carina Ruggiero, science writer and blogs editor, Peter Simons, personal stories editor, Emmeline Mead, community moderator, Steve McCrea, and family resources editor, Miranda Spencer. Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow.

This week on the Pro-Life America podcast, we talk about the culture of death, the glorifying of assisted suicide, and how abortion is the root of it all. Topics Discussed: Listener Question from Ricky F.Chuck Schumer accidentally confirms population bustBritish Courts Uphold law allowing Down Syndrome babies to be aborted up until birthThe Simons Assisted Suicide Ad Campaign That's Gone Viral Links Mentioned:The Dirty Little Secret in the Immigration Battle - Life Dynamics BlogPro-Life America Podcast Episode 46: The Alarming Decline of Birth Rates WorldwideBritish Court OKs Killing Babies in Abortions Up to Birth Just Because They Have Down Syndrome - LifeNews"What kind of society do you want to live in?": Inside the country where Down syndrome is disappearing - CBS NewsCanadian Capitalist Culture Of Death - The American ConservativeThe 30 second “All is Beauty Ad”Full “All Is Beauty Ad”Radio Interview with Peter SimonsRate & Review Our Podcast Have a topic you want to see discussed on the show? [Submit it here.]To learn more about what Life Dynamics does, visit: https://lifedynamics.com/about-us/Support Our Work Be Sure To Follow Life Dynamics:Our WebsiteFacebookTwitterInstagramYouTubeRumble 

The European Union plays an important role and impacts the Brainport region. It influences our work and how we learn and what we can do with our earned degrees within the EU. On a regional level, we talk a lot about the main problem in Brainport, that we need more engineers and high-tech specialists. More education to get more engineers working, so to say. The conference Learning and Working on November 15 in the Park Theater in Eindhoven will dive into this. Peter Simons, Radio4Brainport, interviewed Jacques Giesbertz (Europe Direct) the organizer of this event. He gives some insight what you can expect. --- Send in a voice message: https://anchor.fm/podcasts-4-brainport/message

To start the season, Peter Simons, now chief merchant of THE oldest private family business in Canada and fashion retailer Simons Inc.  We talk about succession planning, the importance of a family council, following consumer trends and frontierless commerce, as well as sourcing in Canada.

In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. This month, Peter Simons covers in detail a new systematic review that debunks the widely popularized myth of low serotonin in depression, the “chemical imbalance theory.” He then follows up with a study that found less than 25% of people respond to depression treatment in real life, and a study that found that screening for depression in adolescents is ineffective. No Evidence Low Serotonin Causes Depression Response to Criticism of Our Serotonin Paper Less Than a Quarter of Those with Depression Respond to Treatment in Real Life Psychiatric Drugs Do Not Improve Disease or Reduce Mortality Screening for Depression in Adolescents Does Not Prevent Hospitalizations or Suicide Attempts

In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. Articles covered in this podcast include: How the mental health app Cerebral is facing accusations of dangerous and unethical practices; How Biogen withdrew its European application for failed Alzheimer's drug aducanumab; How pharma company Cassava was the subject of a New York Times exposé on its Alzheimer's research and outcome data; How social media influencers are the new pharma marketers; Researchers document how psychiatric textbooks and reviews endorsed the chemical imbalance myth; A study finding that antidepressants don't improve quality of life; A study on antidepressants' dangerous effects on the fetus if taken during pregnancy; A paper explaining the difference between antidepressant withdrawal and relapse; A paper on the dangers of benzodiazepine withdrawal; A study finding that a sense of meaningfulness in life protects against mental distress; and A paper by Joanna Moncrieff on the ties between the commodified mental health system and neoliberal capitalism.

On this week's edition of the CEO Series, Karl Moore sits down with Peter Simons, newly stepped down CEO and now Chief Merchant of La Maison Simons, one of Canada's largest retailers and indeed the longest private family-owned business. Tune in to hear them discuss the history of Simon's, what's next for Peter, and the future of the retail industry.

In this 30-minute podcast, Peter Simons reports on the latest scientific articles in psychiatry. The goal is to provide more detail than is usually found in conventional research news and to help listeners understand how to interpret the findings. Articles covered in this podcast include: Researchers write that “psychology is fundamentally incompatible with hypothesis-driven theoretical science”; Researchers suggest that “evidence-based medicine” is more corporate gimmick than reliable science; Psychiatrists deliver the lowest-quality healthcare of any medical specialty; A report by the Council of Europe promotes non-coercive mental health treatment; Black patients in the US were more than twice as likely to be described negatively in electronic health records; A peer-supported Open Dialogue program shows early success in the UK; Antipsychotics are often prescribed without informed consent; Antidepressants are ineffective for children and adolescents; Psychiatric drugs increase dementia risk threefold after COVID in 65+ population; and Official guidelines on antidepressant discontinuation fail practitioners and patients.  

On May 8, Sunday you can walk into the Parktheater in Eindhoven. It is the Kick Off of the Peace Talent Contest. How creative are you in making something that promotes Peace? A Poem, a surprise box for kids, a statue, whatever peace of art. Exact time and more can be found on stapjesnaarvrede.nl. Listen to the interview by Peter Simons with Kees Minderhout. Photo Yaw Kuma Ansu-Kyeremeh --- Send in a voice message: https://anchor.fm/podcasts-4-brainport/message

Peter Simons covers a study in Nature finding that the positive results of psychiatry's brain imaging studies are false; a study demonstrating that more than half of negative antidepressant trials remain unpublished or are misleadingly “spun” as positive; an article that may explain why some people don't find meditation to be helpful; and more! Nature: Brain Imaging Studies Are Most Likely False Negative Antidepressant Trials Still Unlikely to Be Published Did Pharma Companies Hide Failed ADHD Drug Studies From Regulators? Study Discovers Extensive Undisclosed Conflicts of Interest in Medical Research Esketamine: Dangers and Lingering Questions Antipsychotics Worsen Cognitive Functioning in First-Episode Psychosis Your Mindset Matters When You Meditate

Peter Simons and Bernard Leblanc, John Moore, Tom Mulcair, Dr. Mitch Shulman, Christian Borys, Tony Chapman

Incursion dans l'univers complotiste avec le journaliste Tristan Péloquin. Moment historique alors que Peter Simons quitte la direction des magasins Simons. Pierre Marion, le fils de Charles, présente dans un livre la version familiale dans 82 jours: l'affaire Charles Marion. Moment touchant pour le fils de Gilles Charest alors qu'il a visité le plateau de tournage de District 31 avec le commandant Chiasson ! Et finalement, pour souligner le printemps, Bertrand Dumont présente son plus récent bouquin, Étonnantes histoires de fruits.  Voir https://www.cogecomedia.com/vie-privee/fr/ pour notre politique de vie privée

L'éditorial de Richard Martineau : Macron en avance chez les LGBTQ2+. La productrice russe qui a interrompu le bulletin de nouvelles. La Rencontre Lisée - Mulcair avec Jean-François Lisée, ancien chef du Parti québécois et chroniqueur politique, et Thomas Mulcair, ancien chef du NPD et analyste politique (La Joute, chroniqueur au Journal) : le discours de Zelensky à la Segment LCN avec Richard et Jean-François Guérin : le discours de Zelensky à la Chambre des communes. Les cas de COVID-19 en hausse en Europe.  Chronique Crime et Société avec Félix Séguin, journaliste au Bureau d'enquête de Québecor : le chef du SPVM démissionne. Une fillette de 10 ans met fin à ses jours.  Entrevue avec Yann Breault, chargé de cours au département de science politique de l'UQAM et codirecteur de l'Observatoire de l'Eurasie : interruption d'un journal télévisé russe par une manifestante, la protestataire a été condamnée à une amende et est maintenant libérée, ce qui soulève beaucoup de questions. Est-ce une mise en scène de Poutine ? Que se cache-t-il réellement derrière cette histoire? La Rencontre Proulx-Martineau avec Gilles Proulx, chroniqueur au Journal de Montréal Journal de Québec : le discours du président Zelensky à la Chambre des communes. Sonia Lebel et les langues officielles.  La Rencontre Daoust-Martineau avec Yves Daoust, directeur de la section Argent du Journal de Montréal et du Journal de Québec : l'inflation, l'essence et le prix des aliments. Charest muet sur ses derniers mandats. Peter Simons cède les commandes de l'entreprise fondée par sa famille il y a 182 ans. Entrevue avec Marcel Boyer, professeur émérite d'économie à l'Université de Montréal : le professeur avait écrit cette lettre d'opinion dans La Presse en 2018 : « le faux débat sur le privé en santé ». Ce débat s'applique toujours en 2022 et est au cœur des préoccupations électorales provinciales.  Chronique de Christian Rioux, correspondant à Paris pour le quotidien Le Devoir : le dernier sommet européen sur l'Ukraine a été un échec. Pourquoi? Parce que l'Allemagne est complètement dépendante du gaz russe.  La Rencontre Bock-Côté - Martineau avec Mathieu Bock-Côté, chroniqueur blogueur au Journal de Montréal Journal de Québec et animateur du balado « Les idées mènent le monde » à QUB radio : le discours du président Zelensky à la Chambre des communes. Entrevue avec Joseph De Koninck, Professeur émérite au Laboratoire du sommeil de l'Institut de recherche sur le cerveau de l'Université d'Ottawa : le Sénat américain a approuvé hier un projet de loi pour abolir le changement d'heure. Si celui-ci est aussi approuvé par la Maison-Blanche, les Américains conserveront l'heure d'été toute l'année. Or, la Société Canadienne du Sommeil préconise l'abolition du changement d'heure pour garder l'heure normale et non l'heure avancée.  Une production QUB radio Mars 2022 Pour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

La Rencontre Daoust-Martineau avec Yves Daoust, directeur de la section Argent du Journal de Montréal et du Journal de Québec : l'inflation, l'essence et le prix des aliments. Charest muet sur ses derniers mandats. Peter Simons cède les commandes de l'entreprise fondée par sa famille il y a 182 ans. Pour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Entrevue avec Bernard Leblanc, nouveau président et chef de la direction de Simons et Peter Simons, qui quitte son poste à la tête de la maison Simons : Peter Simons quitte son poste à la tête de Simons, et cède sa place à Bernard Leblanc. Pour la première fois, ce ne sera pas un Simons à la tête de la populaire chaîne de magasins.  Pour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Peter Simons covers a study that found both therapy and medication to have very limited effectiveness; an article suggesting that general practitioners need to prescribe fewer antidepressants; a study that concluded no brain imaging test has been able to identify a meaningful brain difference in depression; and more! Major Review Finds Limited Effectiveness for Medication and Therapy Family Physicians Must Change Antidepressant Prescribing Practices SSRI Antidepressants Do Not Improve Depression After a Stroke Clinicians and Patients Often Disagree on Mental Health Outcomes No Meaningful Brain Differences in Depression Shifting Away from ECT and Antidepressants for Depression

Peter Simons covers a clinical trial that found lithium ineffective at preventing suicide attempts, an essay by Allen Frances on the overdiagnosis of depression and overprescription of antidepressants, a review of the ineffectiveness and dangers of antidepressants, and an analysis that revealed that esketamine failed five of its six clinical trials. Lithium No Better Than Placebo for Preventing Suicide Attempts New Review: Antidepressants Come with Minimal Benefits, Several Risks Allen Frances Takes on the Over-Prescription of Antidepressants Esketamine Failed in Five of its Six Efficacy Trials Ketamine Withdrawal Has Severe Consequences New Study of Ayahuasca Users Shows Placebo Effect in Action  

Peter Simons covers articles about the validity of psychiatric diagnoses, the medicalization of normal human experiences like grief, and how the pharmaceutical industry co-opts feminist messaging to gain approval for ineffective drugs. Kenneth Kendler: “Implausible” That Psychiatric Diagnoses Even “Approximately True” Neurobiological Explanations Can Foreclose Self-Understanding Medicalizing Grief May Threaten Our Ability to Mourn Research Reveals Mental Health Professionals' Participation in Rape Culture Why the FDA Approved Ineffective Drugs for Low Sexual Desire in Women Overuse of Psychiatric Drugs is Worsening Public Mental Health, Doctor Argues

Alexandre Coupal parle de hockey; Ludovick Bourdages passe à travers les grands titres des journaux; Evelyne Charuest parle du balado du New York Times Welcome to Your Fantasy; Jean-Luc Brassard aborde l'enseignement du ski aux enfants; Normand Voyer explique la chimie des parfums; Evelyne Charuest nous fait part de ses suggestions de littérature jeunesse; la Dre Caroline Quach-Thanh fait le point sur la situation liée à COVID-19; Andréanne Bissonnette se penche sur les lois antiavortement aux États-Unis; Evelyne Charuest parle du spectacle solo de Louis-José Houde Mille mauvais choix; Alexandre Coupal nous livre différentes histoires relatives au mois de décembre; Peter Simons, PDG des magasins Simons, raconte l'histoire familiale des magasins Simons; et l'artiste Vincent Vallières nous fait part de son amour pour la musique des Beatles.

This week, Peter Simons covers a study about the controversial practice of placebo run-in periods in antidepressant studies, a study about withdrawal symptoms being mistaken for relapse, and a book chapter that addresses stigma and discrimination. Researchers Push to End Placebo Run-in Periods in Antidepressant Studies Withdrawal Symptoms Cloud Findings of Antidepressant “Relapse” Trial Experiences of Prejudice and Discrimination in Mental Healthcare

This week, Peter Simons covers studies examining whether mental health literacy and essentialist thinking are associated with stigma against those with mental health problems. He also covers a study finding that psychotherapy is ineffective for the majority of children with depression. Mental Health Literacy Does Not Reduce Stigma, Psychosocial Approaches More Promising Essentialist Thinking May Drive Stigma Against People Diagnosed with Schizophrenia Meta-analysis of Psychotherapy in Children Finds Lackluster Long Term Results

This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continuing controversy around the FDA's approval of Biogen's failed Alzheimer's drug aducanumab. Antipsychotics Linked to Increased Breast Cancer Risk Screening for Depression in Primary Care Does Not Improve Outcomes Alzheimer's Drug Controversy Continues

This week, Peter Simons covers studies on the biological mechanism behind antipsychotic drugs' association with dementia; surprising brain imaging findings with implications for antidepressant effectiveness; bias in the psychotherapy literature; and the trauma caused by involuntary treatment of people with psychosis. Antipsychotics Increase Risk of Dementia; New Research Illuminates Why Antidepressant Effects on Serotonin Plateau at the Minimum Recommended Dose Selective Reporting Inflates Effectiveness for Psychotherapy Depression Treatments Psychosis Associated with Childhood and Health Care-Related Traumas

This week, Peter Simons covers three studies about financial ties to the pharmaceutical industry in editorial and commentary writers in medical journals. These conflicts of interest create biased research literature that helps pharma push potentially harmful and less effective drugs.   Conflicts of Interest Linked to“Unduly Favorable” Editorials Conflicts of Interest in Medical Commentaries Undermine Credibility of Major Journals How Pharma Pushes New, Less Effective Drugs on the Market

This week, Peter Simons covers two articles about the pharmaceutical industry's influence on drug regulators, and an article finding that newborn babies experience antidepressant withdrawal if their mothers took SSRIs while pregnant. 75% of Pharma Companies Fail Basic Transparency Measures How to Address the Undermining of Drug Regulators by Pharma Newborn Babies Go Through Antidepressant Withdrawal

This week, Peter Simons covers three new articles which suggest that “relapse” in the drug trials for both antidepressants and antipsychotics is likely caused by sudden withdrawal. This contradicts the notion that the drugs have protective effects against relapse. “Relapse” in Antidepressant Trials Likely Caused by Sudden Withdrawal Sudden Antipsychotic Withdrawal—Not Low Dose—Leads to Relapse Tapered Antipsychotic Withdrawal Mitigates Risk of Psychotic Symptoms

This week, Peter Simons covers a BMJ investigation that found the FDA's "accelerated approval" process has left ineffective drugs on the market, some for more than 20 years, without follow-up studies to demonstrate efficacy. He also covers further developments in the FDA and Biogen controversy around Alzheimer's drug aducanumab (Aduhelm). FDA's “Accelerated Approval” Process Leaves Ineffective Drugs on the Market Do we all have Alzheimer's? Drug makers might want you to think so Biogen pulled Aduhelm paper after JAMA demanded edits Acting FDA Chief Janet Woodcock Ruled Out as Biden Nominee Sage Therapeutics axes 2 zuranolone trials deemed unnecessary for approval in depression

This week, Peter Simons covers a BMJ story that concluded 20% of health research is fraudulent, as well as a Lancet Psychiatry piece that critiques the research on long-acting injectable antipsychotics and debunks the claim that they are better than regular oral antipsychotics. BMJ: 20% of Health Research Is Fraudulent Researchers Debate Benefits of Long-Acting Injectable Antipsychotics  

This week, Peter Simons covers two articles in which researchers critique the medical model of psychiatry and propose alternatives. Researchers Critique the Medical Model, Propose an Alternative Medical Sociologist Details the Failures of American Psychiatry

~If you would like to subscribe to only interviews by Retail Insider, a separate "The Interview Series" podcast show is now available (link to Apple Podcast show)~Craig and Peter discuss La Maison Simons struggles through COVID and plans for beyond.**Podcast Sponsor: Swyft is a rapidly growing Canadian same-day shipping company that has partnered exclusively with Retail Insider. Learn more about Swyft's scalable, affordable best-in-class last mile solution.  Interviewed this episode:Peter Simons, President and Chief Executive Officer of La Maison Simons.La Maison Simons The Interview Series podcast by Retail Insider Canada is available on Apple Podcasts, Stitcher, TuneIn, Google Play, or through our dedicated RSS feed for Overcast and other podcast players. Also check out our The Weekly podcast where Craig and Lee discuss popular content published on Retail Insider which is part of the The Retail Insider Podcast Network. Subscribe, Rate, and Review our Retail Insider Podcast!Follow Craig: LinkedIn: www.linkedin.com/in/CraigPattersonTorontoInstagram: @craig_patterson_torontoTwitter: @RI_EIC Follow Retail Insider: LinkedIn: www.linkedin.com/company/Retail-InsiderFacebook: https://www.facebook.com/RetailInsider/Twitter: @RetailInsider_Instagram: @Retail_Insider_Canada Listen & Subscribe:Apple PodcastsSpotifyOvercastStitcher Share your thoughts! Drop us a line at Craig@Retail-Insider.com. You can also rate us in Apple Podcasts or recommend us in Overcast to help more people discover the show! Background Music Credit: Hard Boiled Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 License. http://creativecommons.org/licenses/by/3.0/

This week, Peter Simons provides an update on the FDA's controversial approval of Alzheimer's drug aducanumab, a new guideline for psychoeducation about ADHD, a study linking poverty rates and youth suicide, and an article providing essential information about antidepressant withdrawal. Federal Investigation into FDA Approval of Alzheimer's Drug Guideline for Education about ADHD Poverty Rates in US Counties Predict Youth Suicide Risk Four Essential Studies on Antidepressant Withdrawal Every Prescriber Must Read

This week, Peter Simons covers an article from a trauma survivor who describes the harms of screening, an article that found no genetic links to suicide risk, and an article that found animals were far better than humans at supporting grieving people. A Trauma Survivor Explains the Harms of Screening Study Finds No Genetic Correlations with Suicide Risk Pets More Effective for Grief Support than Humans, Study Finds

This week, Peter Simons covers the latest news on the FDA's approval of failed Alzheimer's drug aducanumab, against the recommendation of its own advisory committee, which led to three members of the committee resigning in protest. He also covers an article confirming yet again that the FDA's black box warning that antidepressants can cause suicide did not increase suicides. Finally, he covers a study that reveals what exactly service users value about hearing voices groups, and why they are so important. FDA Approves Failed Drug Against Advisory Committee Recommendation No, the FDA's Black Box Warning Did Not Increase Suicides Qualitative Study Highlights the Meaning and Impact of Hearing Voices Groups

  This week, Peter Simons covers an article finding that short, simple psychotherapy when discontinuing antidepressants is just as good at preventing relapse as continuing the drug. He also covers a study that found little difference in inflammation between people with and without the depression diagnosis. Finally, he covers a study finding that non-replicable studies are cited more often than replicable studies in the social sciences. Psychotherapy Can Prevent Relapse When Discontinuing Antidepressants https://www.madinamerica.com/2021/05/disentangling-link-inflammation-depression/ Disentangling the Link Between Inflammation and Depression https://www.madinamerica.com/2021/05/disentangling-link-inflammation-depression/ Hype Trumps Rigorous Science in Social Science Publications https://www.madinamerica.com/2021/06/hype-trumps-rigorous-science-social-science-publications/ Visit madinamerica.com for more news, articles and research updates. V2

This week, Peter Simons covers an article finding that anticholinergic drugs are linked to cognitive impairment, an article by Allen Frances about overprescription of antidepressants, and an article warning about reductionistic assumptions about biomarkers in psychiatry.   Anticholinergic Medications Linked to Cognitive Impairment in Schizophrenia   Allen Frances Takes on the Over-Prescription of Antidepressants   We Need Clear Thinking About Biomarkers in Psychiatry to Avoid Bioreductionism Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers an article in JAMA by FDA advisory committee members that reveals ethical issues with the FDA's collaboration with pharmaceutical company Biogen to re-analyze their two failed trials of Alzheimer's disease drug aducanumab. He also covers a study that found that viewing mental health as a continuum reduces stigma. Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug Viewing Mental Differences on a Continuum Reduces Stigma Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers a study that found evidence for overdiagnosis of ADHD in children and adolescents, a study about suicide prevention in men, and findings regarding race and gender in PTSD. Study Confirms Overdiagnosis of ADHD in Children and Teens Encouraging Men to Talk about Suicide can Miss the Point Racial and Gender Discrimination Impacts PTSD Severity Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers a Cochrane review that found no good evidence on how antidepressant withdrawal, a study that found that antidepressants are not useful for back pain, and a study that found that having financial debt led to later mental health problems. Cochrane Review Calls for More Research on Antidepressant Withdrawal Antidepressants Not Clinically Useful for Back Pain Financial Debt Predicts Poor Mental Health Outcomes Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers a study that found the validity of RCTs on schizophrenia and bipolar disorder treatments is very often severely compromised by publication bias and outcome reporting bias. He also covers a study that finds that no models, including clinical judgment or machine learning, are able to successfully predict suicide risk. Finally, he covers a paper that addresses the lack of guidance available for discontinuing psychiatric drugs. Misreporting Results and Publication Bias Common in Psychiatry Research Mental Health Professionals and AI Tools Fail to Predict Suicide Lack of Guidance Available for Discontinuing Psychiatric Drugs Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers a study that found prescribing rates for ADHD drugs did not increase after positive evidence from the MTA study was published, nor decrease when negative evidence from the same study's long-term arm was published. He also covers a study that found physician disclosure of financial conflicts of interest has not changed behavior to reduce industry bias. Stimulant Prescribing Patterns for ADHD Not Impacted by Scientific Evidence Transparency is Not Enough to Stem Tide of Pharma Influence on Medicine Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers a study of almost 15,000 ECT users which found that the treatment did not reduce suicide risk compared with usual care, as well as an audit of ECT use in England which found very little oversight and a lack of outcome measures. He also covers a pharmaceutical industry-sponsored study that tested a new way to reduce the placebo effect so that newly developed drugs appear more effective. New Study Finds ECT Ineffective for Reducing Suicide Risk Audit of Electroconvulsive Therapy Reveals Poor Administration and Monitoring Researchers Attempt to Reduce the Placebo Effect in Drug Trials Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers the first peer-reviewed scientific article with specific guidance for discontinuing antipsychotic drugs, a study that found transcranial magnetic stimulation no better than sham treatment for bipolar disorder, and an FDA drug safety communication about the risk of heart arrhythmias with anticonvulsant drug lamotrigine (Lamictal). Major Publication on Tapering Antipsychotics Released Transcranial Magnetic Stimulation (TMS) Ineffective for People with Bipolar Disorder FDA Drug Safety Communication for lamotrigine Visit madinamerica.com for more news, articles and research updates.

This week, Peter Simons covers an article that finds antidepressants linked with increased suicide risk, an article that describes the ways in which doctors misdiagnose antidepressant withdrawal as medically unexplained symptoms or functional neurological disorders, and an article that finds that being involuntary hospitalized reduces trust in authority figures and makes young people less likely to seek further treatment. Antidepressants Still Linked to Increased Suicide Risk Involuntary Hospitalization Deters Youth from Seeking Mental Healthcare Antidepressant Withdrawal Misdiagnosed as Functional Disorder Visit madinamerica.com for more news, articles and research updates.

Qui sera imputable des situations de maltraitance relevées au Manoir Liverpool ? Dans un élan d'exaspération, Paul Arcand indique clairement que les procédures d'inspection en place ne fonctionnent pas et ne permettent pas de garantir la sécurité des patients. Le PDG du CISSS Chaudière-Appalaches et actuel directeur de la campagne de vaccination contre la Covid-19 au Québec, Daniel Paré, se défend de n'avoir rien vu pendant des années.  Et après plus de six semaines de fermeture, on souligne la réouverture des commerces non-essentiels avec Peter Simons, PDG des magasins Simons.  Voir https://www.cogecomedia.com/vie-privee/fr/ pour notre politique de vie privée

How did Simons grow from a Quebec-based family business to a brand with national recognition? This week on the CEO Series, Karl Moore of McGill University's Desautels Faculty of Management speaks with Peter Simons, CEO of La Maison Simons about the evolution of the retail business through the years.

Entrevue avec Louis-Philippe Messier, chroniqueur au Journal 24 heures : tandis que le grand froid s’installe à Montréal, Louis-Philippe Messier du journal 24 hrs a passé une nuit dans l’hôtel refuge aménagé à la Place Dupuis au centre-ville de Montréal pour les personnes en situation d’itinérance.  Chronique de Nicole Gibeault, juge à la retraite : retour sur l’acquittement de Gilbert Rozon.  Entrevue avec Catherine Beauvais-St-Pierre, présidente de l’Alliance des professeures et professeurs de Montréal : 40% des écoles québécoises sont aux prises avec la COVID-19 en ce moment, mais les écoles primaires et spécialisées reviendront en présentiel après les fêtes. Est-ce que le ministre Roberge joue avec le feu?  Entrevue avec Peter Simons, PDG des magasins Simons : le confinement des commerces non essentiels dès le 25 décembre ; quel effet sur les commerçants?  Chronique de Danny St Pierre, animateur du balado L’Addition à QUB radio : les 6 actualités alimentaires de 2020 selon Sylvain Charlebois. Chronique de François Lambert : les grandes surfaces qui resteront ouvertes ne pourront vendre que des biens essentiels. Le bitcoin dépasse 20 000$ pour la première fois. Un prêt d’Investissement Québec de 30 millions $ pour créer 700 emplois. Segment LCN avec Michel Jean : Réaction aux nouvelles mesures annoncées hier.   Entrevue avec Geneviève Rioux, présidente de la Fédération des familles d'accueil et des ressources intermédiaires du Québec : des bébés seront installés par la DPJ sur une base de plein air en Mauricie à cause de manque de places dans des familles. Chronique de Varda Étienne : quoi faire avec ces vedettes qui se permettent de bafouer les mesures sanitaires?  Entrevue avec Alix Dufresne, coorganisatrice d’une sentinelle en soutien à Annick Charette et les victimes d’agressions sexuelles : une sentinelle à la chandelle aura lieu ce soir en réaction à l’acquittement de Gilbert Rozon.  Chronique Léa Stréliski, humoriste et autrice : Rozon et l’épuisante réalité d’être une femme. Le congé scolaire allongé.  Chronique de Pierre Nantel : le secteur des arts particulièrement miné par la pandémie.   Une production QUB radio Décembre 2020 Pour de l’information concernant l’utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Entrevue avec Peter Simons, PDG des magasins Simons : le confinement des commerces non-essentiels dès le 25 décembre ; quel effet sur les commerçants?  Pour de l’information concernant l’utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Entrevue avec Robert Beaudry à propos de la programmation hivernale de Montréal; chronique musicale de Catherine Richer; la révision du jugement d'Alexandre Bissonnette; discussion avec Peter Simons à l'approche des soldes d'Après-Noël; reportage sur un commerce de proximité; état des lieux sur les stationnements incitatifs; et le point de vue de Jade Bourdages sur l'affaire de maltraitance de Granby.

Wireless access to the Internet is booming, but that also leads to severe congestion of the airwaves. In fact, most complaints about poor WiFI have little to do with poor coverage but rather are caused if too many people use WiFi at the same time. The EU Horizon 2020 ELIoT project is an Innovation Action to use light to communicate. These signals do not go through the wall and that turns out to be a major advantage: you are not affected by interference from others. It gives latency-free connections. Peter Simons of Radio4Brainport.org interviews the ELIoT project leader Prof. Jean-Paul Linnartz. --- Send in a voice message: https://anchor.fm/podcasts-4-brainport/message

Entretien avec Peter Simons, pdg de Simons; duo inter avec Michèle Ouimet et Agnès Gruda; discussion sur les chansons marquantes des campagnes électorales; et trio santé avec Denis Fortier, Sonia Lupien et la Dre Chantale Vallée.

A conversation with Peter Simons about the philosophy of science, the largely unsubstantiated nature of many contemporary assumptions about psychiatric diagnoses and medication-based treatments, and suggestions for being an informed consumer of mental health related research. Peter critically analyzes pharmaceutical research, genetic prediction models, and fMRI studies and discusses the lasting value of existential philosophy. For more on Peter, links from the conversation, and then APA citation for this episode visit www.thethoughtfulcounselor.com. The Thoughtful Counselor is created in partnership with Palo Alto University’s division of Continuing & Professional Studies. Learn more at www.paloaltou.edu/concept.

Welcome to the The Voice of Retail, I'm your host Michael LeBlanc, and this podcast is brought to you in conjunction with Retail Council of Canada, and this episode is brought to you by omNovos. Create the personalized interactions that your customers will actually look forward to with omNovos – Canada's Retail Customer Engagement Solutions Provider. Combine all of your customer data into a single view. Learn more at www.realcustomerengagement.com First up on this episode an exclusive interview with Peter Simons, CEO of La Maison Simons, live from Quebec City.   Started in 1840 and still a family owned and operated Canadian department store, Peter talks about the history of this storied retail brand, the expansion out of Quebec across Canada, and brings us up to date on the current state of the business, his perspective  on the future of the department store format and tells all about their Fabrique 1840 initiative, which creates a marketplace for bespoke local creators across Canada on the Simons web site and beyond.Next up the one and only Willy Kruh is back on the podcast.  The recently retired  Partner and Global Chair Consumer & Retail at KPMG International and frequent top ranked presented at RCC's annual STORE conference, Willy steps back into the ring with his analysis of the current state of retail, what the COVID-19 era means from millennials and other consumers, and wise advise honed by decades of working with c-level retail and brand executives from around the world on how retailers can survive the crisis.But first, lets check in with Peter Simons******Thanks to Peter and Willy for being my guests on this episode, and thanks to omNovos for their support of this episode and The Voice of Retail podcast.   If you liked this podcast you can subscribe on Apple iTunes or your favourite podcast platform, please rate and review, and be sure and recommend to a friend or colleague in the retail industry.I'm Michael LeBlanc, Founder and President of M.E. LeBlanc and Company Inc. and you can learn more about me on www.meleblanc.co or of course on LinkedInUntil next time, have a safe week!

Michel Labrecque explique comment les garderies cohabitent avec le virus; Peter Simons raconte comment il compte s'y prendre pour rouvrir ses commerces; Akli Aït Abdallah fait la lumière sur la situation dans le quartier de Montréal-Nord; Élise Legault se penche sur un éventuel vaccin universel contre le coronavirus; Frank Desoer fait le point sur le déconfinement aux États-Unis et en Europe; Janic Tremblay s'intéresse aux visières conçues par des internautes possédant une imprimante 3D; Frank Desoer dresse le portrait de la première ministre de la Nouvelle-Zélande, Jacinda Ardern; Marie-France Abastado rencontre des professionnels de la santé spécialisés en soins à domicile; et Steven L. Kaplan discute de la tendance consistant à faire son propre pain.

In this bonus episode of the Truck & Driver podcast, we revisit an interview that Dougie Rankine (Editor of Truck & Driver) did with industry consultant Peter Simons last year. A fascinating in-depth look at the origins of DAF's ATi model range, the launch of the 95 and how the Foden Alpha got its name

Welcome to MIA Reports, showcasing our independent and original journalism devoted to rethinking psychiatry. We take selected MIA Reports and provide them as audio articles. Click here for the text version of this and all of our MIA reports. The Whistleblower and Penn: A Final Accounting of Study 352 Written by Peter Simons, read by James Moore, first published on Mad in America, December 29, 2019. Although the general story of ghostwriting in trials of psychiatric drugs is now pretty well known, the details of the corruption in specific trials are still emerging into the public record, often a decade or more after the original sin of fraudulent publication. The latest study to finally see the full light of day is GlaxoSmithKline’s study 352. Perhaps the most infamous ghostwritten study is GSK’s study 329, which, in a 2001 report published in the American Journal of Psychiatry, falsely touted paroxetine (Paxil) as an effective treatment for adolescent depression. The company paid over $3 billion in penalties for fraud. That same year, study 352 made its first appearance in the research literature. That was when Charles Nemeroff, who in the years ahead would become the public face of research misconduct, “authored” an article on the efficacy of paroxetine for bipolar disorder. It has taken 18 years for the full story of that corruption to become known, the final chapter recently emerging when a large cache of study 352 documents—emails, memos, and other internal correspondence between the key players—was made public. The documents reveal a web of corruption that went beyond the fraud of ghostwriting into the spinning of negative results into positive conclusions, and the abetting of that corruption by an editor of the scientific journal that published the article. The documents also reveal a whitewashing of the corruption by the University of Pennsylvania. However, it was the publication of these documents that provided Jay Amsterdam, an investigator in the trial who turned whistleblower after he smelled a rat, with a chance to say “case closed.” Amsterdam and Leemon McHenry have now published two articles that provide a step-by-step deconstruction of the study—the ghostwriting, the spinning of results, the betrayal of public trust. Here is the story of that whistleblowing. 

On MIA Radio this week, MIA’s Peter Simons interviewed David Cohen, PhD, a social worker, professor of social welfare, and Associate Dean for Research at the Luskin School of Public Affairs of the University of California, Los Angeles. He discussed his path to becoming a researcher focused on mental health, coercive practices, and discontinuation from psychiatric drugs. He studies the social construction of psychoactive drug effects, the union of law and psychiatry within a criminalization/medicalization system and envisions alternatives to the current mental health industrial complex and the medicalization of everyday life. He has also taught in Canada and France, and for over 20 years held a private practice to help people withdraw from psychiatric drugs. He is the author of over 100 book chapters and articles. His first book, published in 1990, was Challenging the Therapeutic State: Critical Perspectives on Psychiatry and the Mental Health System. His latest book, published in 2013, with colleagues, Stuart Kirk, and Tomi Gomory is Mad Science: Psychiatric Coercion, Diagnosis and Drugs.

Interview by Peter Simons. Dr. Mark Horowitz is a training psychiatrist and researcher and recently co-authored, with Dr. David Taylor, a review of antidepressant withdrawal that was published in Lancet Psychiatry, which we've written about here at Mad in America (see here). Their article suggests that tapering off antidepressants over months or even years is more successful at preventing withdrawal symptoms than a quick discontinuation of two to four weeks. Dr. Horowitz is currently completing his psychiatry training in Sydney, Australia, and has completed a PhD in the neurobiology of antidepressants at the Institute of Psychiatry at King's College, London. He is a clinical research fellow on the RADAR study run by University College, London. His research work focuses on pharmacologically informed ways of tapering patients off of medication. He plans to conduct studies examining the best methods for tapering medications in order to develop evidence based guidelines to assist patients and doctors.

"Maybe there's a missing link...Analysis alone won't suffice." Our subject matter expert this week is CIMA member Peter Simons. He talks to Kyle Hannan (AICPA & CIMA, UK) about emotional intelligence, soft skills, competition, lean process, influence and insight, and the importance of management accounting as an 'engaged' profession.   OUR GUEST: A Development and Innovation Specialist with AICPA & CIMA (UK), Peter has a Finance MBA and a long track record of innovative and illuminating research that explores the future of finance.   RESOURCES:  Explore leading research and reports on these topics by visiting CGMA.ORG and clicking on 'reports'. Contact Peter and the research team by emailing finance.research@aicpa-cima.com.   == MORE ABOUT OUR PODCAST ==  YOUR COMMUNITY. Interviews with our international experts are recorded by different members of the AICPA & CIMA team from our offices around the world. While the sound quality may vary, the insights will always be consistently useful. DON'T MISS OUT. Go here to get the latest show every week, automatically and free. Share it easily with colleagues and friends by using the icons on the media player.  TAKE IT FURTHER. Find related CPD/CPE resources at the AICPA Store and the CGMA Store. STAY CONNECTED. Follow #GoBeyondDisruption, @AICPANews and @CIMA_News on social."  PERMISSIONS ©2018 Association of International Certified Professional Accountants (AICPA & CIMA). All rights reserved    ===CAN'T SEE THE LINKS? TRY THESE=== * Project Homepage is https://www.aicpa-cima.com/disruption.html. * AICPA Store is https://www.aicpastore.com/gobeyonddisruption * CGMA Store is https://www.cgmastore.com/products/disruption?utm_source=disruption-podcast&utm_medium=podcast&utm_campaign=cgmastore&utm_content=show-notes

Kendall Barber and her sister Justine started Poppy Barley as a way to order custom footwear online. But now they're ready to open stores across Canada. In this episode, she talks to Peter Simons, who with his brother Richard, grew La Maison Simons to a nationwide brick and mortar shopping destination for the first time in the company's 180-year history. 

Aujourd'hui à l'émission:Jacques Nantel, professeur émérite à HEC Montréal; Chronique urbaine d'Hugo Lavoie; Will Prosper, militant pour les droits civiques, porte-parole du mouvement citoyen Montréal-Nord Républik; Entrevue avec Peter Simons, président-directeur général de Simons; Politique avec Chantal Hébert; Duo Marie Grégoire et Vincent Graton; Entrevue avec Louise Portal, porte-parole du Festival Longue vue sur le court; Sportnographe le matin avec Olivier Niquet et Alexandre Coupal.

Aujourd'hui à l'émission:Jacques Nantel, professeur émérite à HEC Montréal; Chronique urbaine d'Hugo Lavoie; Will Prosper, militant pour les droits civiques, porte-parole du mouvement citoyen Montréal-Nord Républik; Entrevue avec Peter Simons, président-directeur général de Simons; Politique avec Chantal Hébert; Duo Marie Grégoire et Vincent Graton; Entrevue avec Louise Portal, porte-parole du Festival Longue vue sur le court; Sportnographe le matin avec Olivier Niquet et Alexandre Coupal.

La Maison Simons has opened the first net-zero department store in Canada. In this week's CKUA Green Energy Futures feature we talk to Peter Simons, CEO about what it takes to create the first net-zero store in Canada powered by 100% solar energy and heated and cooled by a geothermal system. This new store at Galeries de la Capitale in Quebec City follows on the heals of a Simons store in Edmonton powered in part by solar energy. See our blog and photos http://www.greenenergyfutures.ca/episode/simons-first-net-zero-store-in-canada

Produced in partnership with the Association of International Certified Professional Accountants and on the topic of ‘Readying business for the big data revolution', Russell Goldsmith was joined by the Association's, Associate Technical Director, Peter Simons and Simon Jeffery, Group Manager for Technology & Management Information Systems at Siem Car Carriers. For more information, visit https://www.cgma.org/

Like any other age-old industry, fashion retailers must innovate or die. Peter Simons, President of the Quebec-born La Maison Simons is growing his concept shop style department stores to infuse fashion, art, and cutting edge technologies to create an experience parallel to no other store... The post The Future of Fashion with Peter Simons– October 24, 2017 appeared first on Startup Canada.

Entente entre Netflix et Ottawa; Peter Simons, Directeur général de la Maison Simons. Rapports de la Commissaire à l'environnement et au développement durable : Karel Mayrand, Directeur général au Québec de la Fondation David Suzuki. L'avenir d'Hydro-Québec; Éric Martel, Président-directeur général d'Hydro-Québec.

La sexologue Sylvie Lavallée nous parle de la sortie du film 50 nuances de Grey. Une étude rapporte que plus de 90 % des enfants artistes ont souffert à l'âge adulte de toxicomanie, de dépression, de troubles alimentaires, en plus d'avoir des pensées suicidaires. Serait-ce le cas avec les « enfants de la télé » au Québec? Benoit Dutrizac s'entretient avec Olivier Loubry et Jessica Barker, deux acteurs dont la carrière a débuté à un jeune âge. Richard Martineau rencontre Peter Simons, l'homme à la tête de la Maison Simons. Benoit Dutrizac tente de faire atterrir un avion...

La sexologue Sylvie Lavallée nous parle de la sortie du film 50 nuances de Grey. Une étude rapporte que plus de 90 % des enfants artistes ont souffert à l'âge adulte de toxicomanie, de dépression, de troubles alimentaires, en plus d'avoir des pensées suicidaires. Serait-ce le cas avec les « enfants de la télé » au Québec? Benoit Dutrizac s'entretient avec Olivier Loubry et Jessica Barker, deux acteurs dont la carrière a débuté à un jeune âge. Richard Martineau rencontre Peter Simons, l'homme à la tête de la Maison Simons. Benoit Dutrizac tente de faire atterrir un avion...

Peter Simons, Professor of Philosophy, Trinity College, Dublin, gives a talk as part of the series 'Metaphysics of Powers, Causation and Persons'. A process ontology (Heraclitus, Whitehead, Rescher) takes spatiotemporally extended events and processes as primary entities, enduring things as secondary. A factored ontology (Empedocles, Aristotle, Ingarden) investigates the non-entities in virtue of which there is categorial diversity in the world. Their combination purports to be a grounded universal ontological framework. As such it has not only to account for appearances but also to offer satisfactory solutions to known metaphysical difficulties such as the nature of causation, the status of spacetime, the regularity of the universe, the role of structure, and the emergence of mind. This talk will outline such an ontology and consider how far it does and can meet such desiderata.